With Release of Aperture, Proscia Brings Clinical Labs Closer to Drug Discovery

In Today’s Clinical Lab, Senior Editorial Manager Scott Wallask writes about how Aperture positions clinical labs at the forefront of precision medicine. By surfacing trial-eligible patients at diagnosis and unlocking data-driven revenue streams, Aperture addresses the pressures labs face from shrinking reimbursements and growing demand for novel therapies.